iShares MSCI Pacific ex Japan ETF EPP
Set alert
55.62 USD -0.18 -0.33%
As of Nov 2, 2:27 PM ET
55.51 Day range 55.83
48.93 52-week range 58.56
- YTD
- +10.19%
- 1 year
- +8.39%
- Open
- 55.51
- Prev close
- 55.80
- Mkt cap
- 2.24B
- Vol
- 117.12K
- Avg vol
- 234.81K
- EPS
- 2.99
- P/E
- 18.61
- Div yield
- 3.35%
More statistics
- Low
- 55.51
- High
- 55.83
- Forward P/E
- 0.00
- Beta
- 0.00
- Short ratio
- 0.00
- Inst. own
- 0.00%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 56.04
- 200-d avg
- 55.14
- 1y target
- 0.00
6M chart
Events in this range
- Jun 15, 2026Dividend: 0.82413
Signals (28)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Oct 27, 2026 | 6 days ago |
| MACD: Buy Signal | Oct 13, 2026 | 2 weeks ago |
| SMA: Bearish | Sep 23, 2026 | 1 month ago |
| SMA: Bullish | Sep 17, 2026 | 1 month ago |
| SMA: Bearish | Sep 16, 2026 | 1 month ago |
| SMA: Bearish | Sep 14, 2026 | 1 month ago |
| SMA: Bullish | Sep 11, 2026 | 1 month ago |
| SMA: Bearish | Sep 10, 2026 | 1 month ago |
| MACD: Sell Signal | Aug 26, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 25, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 14, 2026 | 2 months ago |
| SMA: Bullish | Jul 14, 2026 | 3 months ago |
| SMA: Bullish | Jul 14, 2026 | 3 months ago |
| SMA: Bearish | Jul 13, 2026 | 3 months ago |
| SMA: Bullish | Jul 10, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 6, 2026 | 3 months ago |
| SMA: Bearish | Jun 15, 2026 | 4 months ago |
| SMA: Bullish | Jun 12, 2026 | 4 months ago |
| SMA: Bearish | Jun 5, 2026 | 5 months ago |
| SMA: Bearish | Jun 4, 2026 | 5 months ago |
| MACD: Sell Signal | Jun 3, 2026 | 5 months ago |
| MACD: Buy Signal | Jun 2, 2026 | 5 months ago |
| SMA: Bullish | May 20, 2026 | 5 months ago |
| SMA: Bearish | May 19, 2026 | 5 months ago |
| MACD: Sell Signal | May 15, 2026 | 5 months ago |
| MACD: Buy Signal | May 6, 2026 | 6 months ago |
| SMA: Bullish | May 5, 2026 | 6 months ago |
| SMA: Bearish | May 4, 2026 | 6 months ago |
Key statistics
- Market cap
- 0
- Enterprise value
- 0
- Trailing P/E
- 18.70
- Forward P/E
- 0.00
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- EPS (TTM)
- 0.00
- Beta
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 0
- Revenue growth
- 0.00%
- Free cash flow
- 0
- Total cash
- 0
- Total debt
- 0
- Return on equity
- 0.00%
- Shares outstanding
- 0
- Short % of float
- 0.00%
- 50-day average
- 56.04
- 200-day average
- 55.14
Analyst view
Price target (mean) 0.00
Next earnings
Consensus EPS estimate 0.00.
About iShares MSCI Pacific ex Japan ETF
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The underlying index consists of stocks from the following four countries or regions: Australia, Hong Kong, New Zealand and Singapore. The underlying index include large- and mid-capitalization companies and may change over time. The fund is non-diversified.
News
- Disc Medicine (IRON) Achieves Positive Phase 3 Trial Results for EPP Treatment
- Disc Medicine Announces Success on All Primary and Secondary Endpoints in the Pivotal Phase 3 APOLLO Trial of Bitopertin in Adults and Adolescents with Erythropoietic Protoporphyria (EPP)
- Disc Medicine to Host Corporate Webcast to Discuss Topline Results from the APOLLO Phase 3 Trial of Bitopertin in Erythropoietic Protoporphyria (EPP)
- iShares MSCI Pacific ex Japan ETF (NYSEARCA:EPP) Sees Large Growth in Short Interest
- Godzilla's Rebirth: The Yen Roars And Shakes Up Markets
- Japan Inflation Picks Up as Rate-Boost Bets Firm
- SCENESSE® approved for EPP in Canada
- GondolaBio Announces Positive Phase 2a Results Demonstrating 79% Plasma Protoporphyrin IX Reduction and Disease-Modifying Potential of PORT-77 for Erythropoietic Protoporphyria
- Why Japan's $70 billion-plus intervention and a rate hike didn't prop up the yen more
- Disc Medicine Launches Expanded Access Program for Bitopertin for EPP Patients
Your note
Sign in to keep a note on EPP — it syncs with the Stock Master app.